X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-11-15 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.37 | -8,000 | 886,703 | -1% | -$146,933 | ||||||
2023-10-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $13.24 | -8,000 | 894,703 | -1% | -$105,920 | ||||||
2023-10-05 | TARS | Trevejo Jose M. | CHIEF MEDICAL OFFICER | S - Sale | $18.00 | -1,604 | 4,503 | -26% | -$28,872 | ||||||
2023-09-20 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.21 | -8,000 | 902,703 | -1% | -$137,680 | ||||||
2023-08-23 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.23 | -8,000 | 910,703 | -1% | -$137,840 | ||||||
2023-08-15 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.80 | +9,506 | 29,906 | +47% | +$159,701 | ||||||
2023-07-19 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $20.05 | -2,400 | 45,806 | -5% | -$48,120 | ||||||
2023-07-19 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.01 | -103,900 | 918,703 | -10% | -$2,078,984 | ||||||
2023-07-12 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $17.35 | -9,000 | 1,022,603 | -1% | -$156,150 | ||||||
2023-06-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.63 | -8,000 | 1,031,603 | -1% | -$149,040 | ||||||
2023-06-14 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $18.58 | -9,000 | 1,039,603 | -1% | -$167,220 | ||||||
2023-06-08 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $20.01 | -3,100 | 1,041,756 | 0% | -$62,031 | ||||||
2023-06-08 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $20.00 | -100 | 48,086 | 0% | -$2,000 | ||||||
| M | 2023-06-06 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $19.00 | -4,643 | 48,186 | -9% | -$88,231 | |||||
2023-05-17 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.90 | -8,000 | 1,051,703 | -1% | -$127,200 | ||||||
2023-05-10 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $16.80 | -9,000 | 1,059,703 | -1% | -$151,200 | ||||||
| M | 2023-04-28 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.11 | -10,119 | 1,068,703 | -1% | -$152,925 | |||||
2023-04-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.03 | -2,311 | 1,078,822 | 0% | -$34,734 | ||||||
2023-04-20 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.02 | -5,000 | 26,785 | -16% | -$70,100 | ||||||
2023-04-19 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $13.60 | -8,000 | 1,081,133 | -1% | -$108,800 | ||||||
| M | 2023-03-21 | TARS | Greenstein Leonard M. | CFO | S - Sale | $12.55 | -1,004 | 31,785 | -3% | -$12,603 | |||||
| M | 2023-03-21 | TARS | Trevejo Jose M. | CHIEF MEDICAL OFFICER | S - Sale | $12.58 | -1,513 | 6,107 | -20% | -$19,026 | |||||
| M | 2023-03-21 | TARS | Neervannan Seshadri | COO | S - Sale | $12.55 | -1,141 | 54,696 | -2% | -$14,324 | |||||
| M | 2023-03-21 | TARS | Wahl Bryan | GC | S - Sale | $12.55 | -1,078 | 16,402 | -6% | -$13,532 | |||||
| M | 2023-03-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $12.55 | -2,125 | 1,089,133 | 0% | -$26,669 | |||||
| M | 2023-03-21 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $12.55 | -1,004 | 11,219 | -8% | -$12,603 | |||||
| M | 2023-03-21 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $12.55 | -1,078 | 52,829 | -2% | -$13,531 | |||||
| M | 2023-03-17 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $12.94 | -649 | 12,223 | -5% | -$8,396 | |||||
| M | 2023-03-17 | TARS | Wahl Bryan | GC | S - Sale | $12.94 | -696 | 17,480 | -4% | -$9,004 | |||||
| M | 2023-03-17 | TARS | Neervannan Seshadri | COO | S - Sale | $12.94 | -740 | 55,837 | -1% | -$9,573 | |||||
| M | 2023-03-17 | TARS | Trevejo Jose M. | CHIEF MEDICAL OFFICER | S - Sale | $12.94 | -1,034 | 7,620 | -12% | -$13,376 | |||||
| M | 2023-03-17 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $12.94 | -697 | 53,907 | -1% | -$9,016 | |||||
| M | 2023-03-17 | TARS | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale | $12.94 | -386 | 3,191 | -11% | -$4,993 | |||||
| M | 2023-03-17 | TARS | Greenstein Leonard M. | CFO | S - Sale | $12.94 | -649 | 32,789 | -2% | -$8,396 | |||||
| M | 2023-03-17 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $12.96 | -1,536 | 1,091,258 | 0% | -$19,902 | |||||
| D | 2023-03-16 | TARS | Holdbrook Mark J. | VP, Clinical Affairs | S - Sale+OE | $13.43 | -187 | 3,577 | -5% | -$2,511 | |||||
| D | 2023-03-16 | TARS | Wahl Bryan | GC | S - Sale+OE | $13.43 | -337 | 18,176 | -2% | -$4,526 | |||||
| D | 2023-03-16 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $13.43 | -313 | 12,872 | -2% | -$4,204 | |||||
| D | 2023-03-16 | TARS | Trevejo Jose M. | Chief Medical Officer | S - Sale+OE | $13.43 | -499 | 8,654 | -5% | -$6,702 | |||||
| D | 2023-03-16 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale+OE | $13.43 | -336 | 54,604 | -1% | -$4,512 | |||||
| D | 2023-03-16 | TARS | Neervannan Seshadri | COO | S - Sale+OE | $13.43 | -357 | 56,577 | -1% | -$4,795 | |||||
| D | 2023-03-16 | TARS | Greenstein Leonard M. | CFO | S - Sale+OE | $13.44 | -5,313 | 33,438 | -14% | -$71,404 | |||||
| DM | 2023-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale+OE | $13.76 | -8,791 | 1,092,794 | -1% | -$120,943 | |||||
| M | 2023-03-08 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.02 | -5,570 | 1,090,286 | -1% | -$83,654 | |||||
2023-02-16 | TARS | Greenstein Leonard M. | CFO | S - Sale | $15.12 | -5,000 | 34,289 | -13% | -$75,600 | ||||||
2023-02-15 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.28 | -8,000 | 1,095,856 | -1% | -$122,240 | ||||||
2023-02-08 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.14 | -9,000 | 1,103,856 | -1% | -$136,260 | ||||||
2023-01-23 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.45 | -4,856 | 1,112,856 | 0% | -$75,025 | ||||||
2023-01-06 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.00 | -411 | 1,131,490 | 0% | -$6,165 | ||||||
2023-01-19 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.56 | -5,000 | 39,289 | -11% | -$72,800 | ||||||
| M | 2023-01-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $14.57 | -8,240 | 1,118,123 | -1% | -$120,080 | |||||
2023-01-11 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.11 | -3,904 | 1,126,363 | 0% | -$58,989 | ||||||
| M | 2023-01-09 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.16 | -1,634 | 1,130,267 | 0% | -$24,773 | |||||
2022-12-21 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $14.57 | -8,000 | 1,131,901 | -1% | -$116,560 | ||||||
2022-12-16 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.01 | -535 | 1,139,901 | 0% | -$8,030 | ||||||
2022-12-15 | TARS | Greenstein Leonard M. | CFO | S - Sale | $14.64 | -5,000 | 44,289 | -10% | -$73,200 | ||||||
2022-12-14 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $15.08 | -6,420 | 1,140,436 | -1% | -$96,814 | ||||||
2022-12-02 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $16.90 | -1,154 | 8,723 | -12% | -$19,503 | ||||||
2022-12-02 | TARS | Wahl Bryan | GC | S - Sale | $16.90 | -1,154 | 13,723 | -8% | -$19,503 | ||||||
| DM | 2022-11-30 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $16.62 | -2,347 | 9,877 | -19% | -$39,017 | |||||
| DM | 2022-11-30 | TARS | Wahl Bryan | GC | S - Sale+OE | $16.62 | -2,347 | 14,877 | -14% | -$39,017 | |||||
2022-11-17 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.54 | -5,000 | 49,289 | -9% | -$82,700 | ||||||
2022-11-16 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $16.86 | -8,000 | 1,146,856 | -1% | -$134,853 | ||||||
2022-11-15 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $17.72 | -6,857 | 49,729 | -12% | -$121,506 | ||||||
2022-11-09 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $17.87 | -9,000 | 1,154,856 | -1% | -$160,830 | ||||||
2022-10-20 | TARS | Greenstein Leonard M. | CFO | S - Sale | $15.92 | -5,000 | 54,289 | -8% | -$79,589 | ||||||
2022-10-19 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $16.92 | -8,000 | 1,163,856 | -1% | -$135,349 | ||||||
2022-10-12 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $15.91 | -9,000 | 1,171,856 | -1% | -$143,194 | ||||||
2022-09-21 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $16.31 | -8,000 | 1,180,856 | -1% | -$130,475 | ||||||
2022-09-15 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.03 | -5,000 | 59,289 | -8% | -$80,150 | ||||||
2022-09-14 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $16.01 | -9,000 | 1,188,856 | -1% | -$144,090 | ||||||
2022-09-14 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.12 | +18,400 | 18,400 | New | +$296,606 | ||||||
2022-08-18 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.30 | -5,000 | 64,289 | -7% | -$81,500 | ||||||
2022-08-17 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $16.59 | -8,000 | 1,197,856 | -1% | -$132,692 | ||||||
2022-05-05 | TARS | Ackermann Michael | Dir | P - Purchase | $13.50 | +100,000 | 1,304,016 | +8% | +$1,350,000 | ||||||
2022-05-05 | TARS | Vivo Capital Ix, LLC | 10% | S - Sale | $12.25 | -5,374 | 2,469,001 | 0% | -$65,832 | ||||||
| M | 2022-05-02 | TARS | Vivo Capital Ix, LLC | 10% | S - Sale | $13.39 | -512,956 | 2,474,375 | -17% | -$6,866,311 | |||||
2021-12-01 | TARS | Ackermann Michael | Dir | S - Sale | $24.68 | -5,833 | 1,204,016 | 0% | -$143,934 | ||||||
2021-12-01 | TARS | Azamian Bobak R. | Pres, CEO | S - Sale | $24.72 | -5,833 | 1,205,856 | 0% | -$144,167 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |